Citigroup Reaffirms “Sell” Rating for Afya (NASDAQ:AFYA)

Citigroup reaffirmed their sell rating on shares of Afya (NASDAQ:AFYA) in a research report sent to investors on Friday morning, Marketbeat reports. Citigroup currently has a $15.00 price objective on the stock, down from their previous price objective of $18.00.

Several other analysts have also recently commented on the stock. JPMorgan Chase & Co. reduced their target price on shares of Afya from $25.00 to $20.50 and set a “neutral” rating for the company in a research note on Friday, January 17th. The Goldman Sachs Group began coverage on shares of Afya in a report on Tuesday, December 3rd. They set a “sell” rating and a $16.00 target price for the company. Two research analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $18.00.

Afya Price Performance

Shares of NASDAQ AFYA opened at $16.15 on Friday. The stock’s 50-day simple moving average is $15.82 and its 200-day simple moving average is $16.66. The firm has a market capitalization of $1.51 billion, a PE ratio of 13.02, a price-to-earnings-growth ratio of 0.27 and a beta of 0.89. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.60 and a current ratio of 1.60. Afya has a fifty-two week low of $14.52 and a fifty-two week high of $22.24.

Hedge Funds Weigh In On Afya

Several institutional investors have recently modified their holdings of AFYA. Cubist Systematic Strategies LLC grew its position in Afya by 136.9% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 35,254 shares of the company’s stock valued at $622,000 after buying an additional 20,370 shares in the last quarter. Millennium Management LLC grew its position in Afya by 45.0% in the 2nd quarter. Millennium Management LLC now owns 291,164 shares of the company’s stock valued at $5,139,000 after buying an additional 90,383 shares in the last quarter. DekaBank Deutsche Girozentrale bought a new position in Afya in the 3rd quarter valued at about $417,000. Lifestyle Asset Management Inc. grew its position in Afya by 13.3% in the 3rd quarter. Lifestyle Asset Management Inc. now owns 16,753 shares of the company’s stock valued at $286,000 after buying an additional 1,969 shares in the last quarter. Finally, Quantbot Technologies LP boosted its position in shares of Afya by 73.8% during the 3rd quarter. Quantbot Technologies LP now owns 13,268 shares of the company’s stock valued at $226,000 after purchasing an additional 5,636 shares in the last quarter. Institutional investors own 88.02% of the company’s stock.

Afya Company Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.